Out of hospital anticoagulant therapy in patients with acute pulmonary embolism is frequently practised but not perfect

Thrombosis Research

Volumn 126, Issue 6, 2010, Pages 481-485

  Van Bladel, Esther R ^a   Agterof, Mariëtte J ^a   Frijling, Bernard D ^b   Van Der Griend, René ^c   Prins, Martin H ^d   Schutgens, Roger E G ^e   Biesma, Douwe H ^a,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Thrombosis Service and Primary Care Diagnostic Centre Saltro   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Home treatment; International normalized ratio; Oral anticoagulant therapy; Pulmonary embolism; Time in range

Indexed keywords

ACENOCOUMAROL; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; DRUG SAFETY; EARLY INTERVENTION; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OUTPATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TREATMENT DURATION;

AMBULATORY CARE; ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT DISCHARGE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78649732813     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.08.019     Document Type: Article

References (25)

1. C. Kearson, S.R. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease*: American college of chest physicians evidence-based clinical practise guidelines (8th edition) Chest 133 2008 454S 545S
2. A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galiè, and P. Pruszczyk Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur Heart J 29 2008 2276 2315
3. H.R. Büller, W.J.J. Assendelft, J.D. Banga, A.C. de Boer, H.J.L. van Gerwen, and I. Hovius Treatment Dutch Institute for Healthcare Improvement CBO. Deep venous thrombosis and pulmonary embolism 1999 Van Zuiden Communications BV Alphen aan den Rijn, The Netherlands 163 236
4. J.J.M. Delemarre, M.V. Huisman, C.J.M. de Groot, D.N. Kolbach, K.W. van Kralingen, and F.W.G. Leebeek Medicinal treatment for venous thromboembolism Dutch Institute for Healthcare Improvement CBO. Guideline for diagnosis, prevention and treatment of venous thromboembolism and secundary prevention of arterial thrombosis 2008 Van Zuiden Communications BV Alphen aan den Rijn, The Netherlands 111 140
5. Federation of Dutch Thrombosis Services Guidebook for outpatient anticoagulation therapy with cumarines 2005 Federation of Dutch Thrombosis Services Den Haag, The Netherlands 8 12
6. S.M. Custódio das Dôres, S.L. Booth, L.A. Martini, V.H. de Carvalho Gouvêa, C.R. Padovani, and F.H. de Abreu Maffei Relationship between diet and anticoagulant response to warfarin: a factor analysis Eur J Nutr 46 2007 147 154
7. M.A. Johnson Influence of vitamin K on anticoagulant therapy depends on vitamin K status and the source and chemical forms of vitamin K Nutr Rev 63 2005 91 97
8. P.S. Wells, A.M. Holbrook, N.R. Crowther, and J. Hirsh Interactions of warfarin with drugs and food Ann Intern Med 121 1994 767 783
9. E.M. Hylek, H. Heiman, S.J. Skates, M.A. Sheehan, and D.E. Singer Acetaminophen and other risk factors for excessive warfarin anticoagulation J Am Med Assoc 279 1998 657 662
10. E.M. Hylek, S. Regan, A.S. Go, R.A. Hughes, D.E. Singer, and S.J. Skates Clinical predictors of prolonged delay in return of the internation normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin Ann Intern Med 135 2001 393 400
11. P. Froom, E. Miron, and M. Barak Oral anticoagulants in the elderly Br J Haematol 120 2003 526 528
12. J. Oldenburg, C.G. Bevans, A. Fregin, C. Geisen, C. Müller-Reible, and M. Watzka Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles Thromb Haemost 98 2007 570 578
13. S. Kumar, J.R. Haigh, L.E. Rhodes, S. Peaker, J.A. Davies, and B.E. Roberts Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy Thromb Haemost 62 1989 729 732
14. N.J. Davis, H.H. Billett, H.W. Cohen, and J.H. Arnsten Impact of adherence, knowledge, and quality of life on anticoagulation control Ann Pharmacother 39 2005 632 636
15. C. van Walraven, A. Jennings, N. Oake, D. Fergusson, and A.J. Forster Effect of study setting on anticoagulation control: a systematic review and metaregression Chest 129 2006 1155 1166
16. J. Hirsh, J. Dalen, D.R. Anderson, L. Poller, H. Bussey, and J. Ansell Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 119 2001 8S 21S
17. J.A. Caprini, V.F. Tapson, T.M. Hyers, A.L. Waldo, A.K. Wittkowsky, and R. Friedman Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs J Vasc Surg 42 2005 726 733
18. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briet A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
19. G. Palareti, N. Leali, S. Coccheri, M. Poggi, C. Manotti, and A. D'Angelo Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy Lancet 348 1996 423 428
20. H.R. Büller, B.L. Davidson, H. Decousus, A. Gallus, M. Gent, and F. Piovella Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism N Engl J Med 349 2003 1695 1702
21. S. Kaatz Determinants and measures of quality in oral anticoagulation therapy J Thromb Thrombolysis 25 2008 61 66
22. D. Aujesky, K.J. Smith, J. Cornuz, and M.S. Roberts Cost-effectinveness of low-molecular-weight heparin for treatment of pulmonary embolism Chest 128 2005 1601 1610
23. J.D. Douketis, G.A. Foster, M.A. Crowther, M.H. Prins, and J.S. Ginsberg Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy Arch Intern Med 160 2000 3431 3436
24. M. Nijkeuter, M. Sohne, L.W. Tick, P.W. Kamphuisen, M.H. Kramer, and L. Laterveer The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study Chest 131 2007 517 523
25. J. Wicki, A. Perrier, T.V. Perneger, H. Bounameaux, and A.F. Junod Predicting adverse outcome in patients with acute pulmonary embolism: a risk score Thromb Haemost 84 2000 548 552